Webinar April 13, 2021: Racial Equity in Study Design: Increasing Minority Participation in Trials

 Register Now

Erace

Promoting Cancer Health Equity

 Learn More

Drive better patient outcomes with leading RWD and AI

 Learn More

Commercial solutions to increase patient adherence

 Learn More

Accelerating innovation for major biopharma

 Learn More

Webinar Series: Oncology Clinical Study Optimization Solutions
Register Now
Improving patient lives with continuous innovation

Leading Enterprise RWE

Integrated RWD and AI

Take the Challenge

Can you accelerate clinical trial innovation?
See External Control Arms

Can you speed up access to better therapies?
See Products

Are you reducing costs and increasing efficiencies?
See Use Cases

Can you improve patient onboarding success?
See Predictive Patient
Independent, Scalable and Specialized

The Industry’s Largest U.S. Oncology RWD

See Our Data
 
0+

EMR Systems

0+

Cancer Clinics

0+

Medical Oncologists

80/20

Community to Academic

Frequent

Data Refreshes

Leading Biopharma Choose ConcertAI

Press Release

Concerto HealthAI Enters Precision Oncology Collaboration with Pfizer

Read More
Press Release

Bristol-Myers Squibb and Concerto HealthAI Announce Strategic Agreement to Broaden Uses of RWE and Accelerate Precision Oncology Innovations

Read More
Press Release

Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen

Read More
Patient-Driven

Continually Advancing Better Patient Outcomes

Improve Patient Outcomes and Accelerate Clinical Trials with the most comprehensive, integrated set of RWD and AI technologies.

Clinical Development

For Improved Patient Outcomes in Oncology

Our experienced team of scientists work with our data and AI technologies to accelerate trial data analysis and to help you implement novel data and analytics techniques for RCTs, pragmatic trials, external controls, or adaptive studies.
Our experienced team of scientists work with our data and AI technologies to accelerate trial data analysis and to help you implement novel data and analytics techniques for RCTs, pragmatic trials, external controls, or adaptive studies.
COMMERCIAL SOLUTIONS

Drive Better
Patient Outcomes
for Diseases

Learn More
  • AML
  • Breast Cancer
  • Cirrhosis
  • Fabry Disease
  • GIST
  • Hemophilia
  • Hepatitis C
  • Leukemia
  • Multiple Sclerosis
  • Myelofibrosis
  • Plaque Psoriasis
  • Prostate Cancer
  • Pulmonary Arterial Hypertension
  • Rheumatoid Arthritis
  • Schizophrenia
  • Tardive Dyskinesia

News & Highlights

Home

ConcertAI Announces Collaboration with Novartis to Use Real-World Data and AI Analytics to Optimize Cancer Care and Improve Patient Outcomes

Read More
Home
Research

ERACE: Fostering New Cancer Care Models that Can Lead to More Equitable Outcomes

Read More
Home
CLINICAL DEVELOPMENT

Predicting Cardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors: An ML Approach

Read More

Innovate with ConcertAI – We’re hiring!

Join the fastest growing AI-powered SaaS and data company in healthcare. We are looking for motivated, curious, independent people dedicated to transforming how healthcare is delivered. Talk to us about how to make an impact.

View Open Jobs
See All Events
On-Demand Webinar

“Living” RWD for Enterprise Evidence Generation

Given the recent rapid pace of innovation, expansion, and adoption in the move to value-based medicine; real-world data can no longer be a series of static, one-time purchases. Rather, the new paradigm of insight and real-world evidence (RWE) generation is lifelong and enterprise-level and requires a living dataset that can grow and evolve with the needs of researchers and the patients they serve.   

Join Warren Whyte, PhD, Vice President of Scientific Partnerships and Customer Success at ConcertAI, for a live webinar on how “living” datasets work and how such advanced oncology RWD can accelerate an enterprise-level approach to RWE.  
Live Webinar

Racial Equity in Study Design: Increasing Minority Participation in Trials

April 13, 2021 10:00 am

Under-representation of minority patients in clinical trials continues to be an ongoing problem. Traditional study criteria and methods don’t capture the different requirements needed to make trials more equitable and representative.

Please join Dr. Jeremy Miller, PhD, and senior director of technical solutions at ConcertAI, for a short webinar on how advanced RWD and AI technologies are helping find more patients from diverse racial backgrounds who are eligible to enroll in oncology trials.

Register Now